Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Brain Metastasis”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableActive Not RecruitingNCT02429570
What this trial is testing

Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary

Who this might be right for
Recurrent Brain MetastasesProgressive Brain Metastases
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00003062
What this trial is testing

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 70
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT01144117
What this trial is testing

The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (Primary or Secondary Progressive Phase).
Rigshospitalet, Denmark 56
Testing effectiveness (Phase 2)Study completedNCT00257855
What this trial is testing

A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
University College London Hospitals 120
Early research (Phase 1)Study completedNCT02423525
What this trial is testing

Safety Study of Afatinib for Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari 24
Testing effectiveness (Phase 2)Study completedNCT00219297
What this trial is testing

Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasisNon-small Cell Lung Cancer
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Looking for participantsNCT05700721
What this trial is testing

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Who this might be right for
Brain Metastases
M.D. Anderson Cancer Center 120
Large-scale testing (Phase 3)Study completedNCT00799890
What this trial is testing

Sunphenon in Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Friedemann Paul 61
Testing effectiveness (Phase 2)Looking for participantsNCT05866432
What this trial is testing

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases

Who this might be right for
Breast Cancer Stage IV
Medical University of Vienna 20
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70
Testing effectiveness (Phase 2)Ended earlyNCT02047747
What this trial is testing

A Phase II Study of Dacomitinib in Progressive Brain Metastases

Who this might be right for
Brain Cancer
David Piccioni, M.D., Ph.D 4
Testing effectiveness (Phase 2)Study completedNCT00085566
What this trial is testing

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Who this might be right for
Brain and Central Nervous System TumorsProstate Cancer
Memorial Sloan Kettering Cancer Center 61
Not applicableStudy completedNCT04858893
What this trial is testing

Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms

Who this might be right for
Primary ParkinsonismSecondary Vascular Parkinson DiseaseMultiple System Atrophy+1 more
Ospedale Generale Di Zona Moriggia-Pelascini 562
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Testing effectiveness (Phase 2)UnknownNCT00551122
What this trial is testing

Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more
University of Southampton 23
Early research (Phase 1)Study completedNCT00513162
What this trial is testing

Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases

Who this might be right for
Neuroectodermal TumorBrain MetastasesAdvanced Cancer
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT03328884
What this trial is testing

Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients

Who this might be right for
Breast Cancer Metastatic
MedSIR 55
Early research (Phase 1)Study completedNCT01904123
What this trial is testing

STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaRecurrent Brain Neoplasm+2 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT01305941
What this trial is testing

Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases

Who this might be right for
HER-2 Positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center 32
Next Page